The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Outlook 2024
Synopsis
Dipeptide Peptidase 4 (DPP-4) Inhibitors are a class of oral diabetes drugs that work by blocking the action of DPP-4, an enzyme which destroys a group of gastrointestinal hormones called incretins. Incretins help stimulate the production of insulin when it is needed (e.g. after eating) and reduce the production of glucagon by the liver when it is not needed (e.g. during digestion). They also slow down digestion and decrease appetite. So by protecting incretins from damage, DPP-4 inhibitors help regulate blood glucose levels.
Januvia (Sitagliptin), Galvus (Vildagliptin), Onglyza (Saxagliptin), Tradjenta (Linagliptin) are the major DPP-4 drugs in the market.
The global Dipeptide Peptidase 4 (DPP-4) Inhibitors market was valued at US$ 8984.2 million in 2020 and is expected to reach US$ 10840 million by the end of 2027, growing at a CAGR of 2.3% during 2021-2027.
This report focuses on Dipeptide Peptidase 4 (DPP-4) Inhibitors volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Dipeptide Peptidase 4 (DPP-4) Inhibitors market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Sitagliptin
Saxagliptin
Linagliptin
Alogliptin
Vildagliptin
Segment by Application
Hospitals
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Merck
Eli Lilly
AstraZenica
Boehringer Ingelheim
Takeda Pharmaceutical Company
BMS
Dipeptide Peptidase 4 (DPP-4) Inhibitors are a class of oral diabetes drugs that work by blocking the action of DPP-4, an enzyme which destroys a group of gastrointestinal hormones called incretins. Incretins help stimulate the production of insulin when it is needed (e.g. after eating) and reduce the production of glucagon by the liver when it is not needed (e.g. during digestion). They also slow down digestion and decrease appetite. So by protecting incretins from damage, DPP-4 inhibitors help regulate blood glucose levels.
Januvia (Sitagliptin), Galvus (Vildagliptin), Onglyza (Saxagliptin), Tradjenta (Linagliptin) are the major DPP-4 drugs in the market.
The global Dipeptide Peptidase 4 (DPP-4) Inhibitors market was valued at US$ 8984.2 million in 2020 and is expected to reach US$ 10840 million by the end of 2027, growing at a CAGR of 2.3% during 2021-2027.
This report focuses on Dipeptide Peptidase 4 (DPP-4) Inhibitors volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Dipeptide Peptidase 4 (DPP-4) Inhibitors market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Sitagliptin
Saxagliptin
Linagliptin
Alogliptin
Vildagliptin
Segment by Application
Hospitals
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Merck
Eli Lilly
AstraZenica
Boehringer Ingelheim
Takeda Pharmaceutical Company
BMS
Index1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Overview
1.1 Product Overview and Scope of Dipeptide Peptidase 4 (DPP-4) Inhibitors
1.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Type
1.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Sitagliptin
1.2.3 Saxagliptin
1.2.4 Linagliptin
1.2.5 Alogliptin
1.2.6 Vildagliptin
1.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Application
1.3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue 2016-2027
1.4.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales 2016-2027
1.4.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Region: 2016 Versus 2021 Versus 2027
2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Competition by Manufacturers
2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2016-2021)
2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturing Sites, Area Served, Product Type
2.5 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Competitive Situation and Trends
2.5.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Dipeptide Peptidase 4 (DPP-4) Inhibitors Players Market Share by Revenue
2.5.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Retrospective Market Scenario by Region
3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.3.1 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country
3.3.2 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.4.1 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country
3.4.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Region
3.5.1 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region
3.5.2 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.6.1 Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country
3.6.2 Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.7.1 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country
3.7.2 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Historic Market Analysis by Type
4.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2016-2021)
4.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type (2016-2021)
4.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Type (2016-2021)
5 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Historic Market Analysis by Application
5.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2016-2021)
5.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Application (2016-2021)
5.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 AstraZenica
6.3.1 AstraZenica Corporation Information
6.3.2 AstraZenica Description and Business Overview
6.3.3 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.3.4 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.3.5 AstraZenica Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Corporation Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Takeda Pharmaceutical Company
6.5.1 Takeda Pharmaceutical Company Corporation Information
6.5.2 Takeda Pharmaceutical Company Description and Business Overview
6.5.3 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.5.5 Takeda Pharmaceutical Company Recent Developments/Updates
6.6 BMS
6.6.1 BMS Corporation Information
6.6.2 BMS Description and Business Overview
6.6.3 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.6.4 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.6.5 BMS Recent Developments/Updates
7 Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturing Cost Analysis
7.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitors
7.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Distributors List
8.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Customers
9 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Dynamics
9.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Trends
9.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Growth Drivers
9.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Challenges
9.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Restraints
10 Global Market Forecast
10.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Type (2022-2027)
10.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Application (2022-2027)
10.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (g) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (g) Comparison by Application (2021-2027)
Table 3. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Dipeptide Peptidase 4 (DPP-4) Inhibitors Covered in This Study
Table 5. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (g) of Key Manufacturers (2016-2021)
Table 6. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Dipeptide Peptidase 4 (DPP-4) Inhibitors Average Price (USD/mg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturing Sites and Area Served
Table 11. Manufacturers Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dipeptide Peptidase 4 (DPP-4) Inhibitors as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2016-2021) & (g)
Table 16. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region (2016-2021)
Table 17. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2016-2021) & (g)
Table 19. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2016-2021)
Table 20. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2016-2021)
Table 22. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2016-2021) & (g)
Table 23. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2016-2021)
Table 24. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2016-2021) & (g)
Table 27. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region (2016-2021)
Table 30. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2016-2021) & (g)
Table 31. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2016-2021)
Table 32. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2016-2021) & (g)
Table 35. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2016-2021)
Table 38. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (g) by Type (2016-2021)
Table 39. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2016-2021)
Table 40. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (Million US$) by Type (2016-2021)
Table 41. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Type (2016-2021)
Table 42. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price (USD/mg) by Type (2016-2021)
Table 43. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (g) by Application (2016-2021)
Table 44. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2016-2021)
Table 45. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (Million US$) by Application (2016-2021)
Table 46. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Application (2016-2021)
Table 47. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price (USD/mg) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 51. Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
Table 52. Merck Recent Developments/Updates
Table 53. Eli Lilly Corporation Information
Table 54. Eli Lilly Description and Business Overview
Table 55. Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 56. Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
Table 57. Eli Lilly Recent Developments/Updates
Table 58. AstraZenica Corporation Information
Table 59. AstraZenica Description and Business Overview
Table 60. AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 61. AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
Table 62. AstraZenica Recent Developments/Updates
Table 63. Boehringer Ingelheim Corporation Information
Table 64. Boehringer Ingelheim Description and Business Overview
Table 65. Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 66. Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
Table 67. Boehringer Ingelheim Recent Developments/Updates
Table 68. Takeda Pharmaceutical Company Corporation Information
Table 69. Takeda Pharmaceutical Company Description and Business Overview
Table 70. Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 71. Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
Table 72. Takeda Pharmaceutical Company Recent Developments/Updates
Table 73. BMS Corporation Information
Table 74. BMS Description and Business Overview
Table 75. BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 76. BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
Table 77. BMS Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Dipeptide Peptidase 4 (DPP-4) Inhibitors Distributors List
Table 81. Dipeptide Peptidase 4 (DPP-4) Inhibitors Customers List
Table 82. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Trends
Table 83. Dipeptide Peptidase 4 (DPP-4) Inhibitors Growth Drivers
Table 84. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Challenges
Table 85. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Restraints
Table 86. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast by Type (2022-2027) & (g)
Table 87. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share Forecast by Type (2022-2027)
Table 88. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 89. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share Forecast by Type (2022-2027)
Table 90. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast by Application (2022-2027) & (g)
Table 91. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share Forecast by Application (2022-2027)
Table 92. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 93. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share Forecast by Application (2022-2027)
Table 94. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast by Region (2022-2027) & (g)
Table 95. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share Forecast by Region (2022-2027)
Table 96. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 97. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share Forecast by Region (2022-2027)
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dipeptide Peptidase 4 (DPP-4) Inhibitors
Figure 2. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Type in 2020 & 2027
Figure 3. Sitagliptin Product Picture
Figure 4. Saxagliptin Product Picture
Figure 5. Linagliptin Product Picture
Figure 6. Alogliptin Product Picture
Figure 7. Vildagliptin Product Picture
Figure 8. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Application in 2020 & 2027
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size 2016-2027 (US$ Million)
Figure 13. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales 2016-2027 (g)
Figure 14. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Manufacturers in 2020
Figure 16. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Dipeptide Peptidase 4 (DPP-4) Inhibitors Players: Market Share by Revenue in 2020
Figure 18. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region (2016-2021)
Figure 20. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region in 2020
Figure 21. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region (2016-2021)
Figure 22. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region in 2020
Figure 23. U.S. Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Type (2016-2021)
Figure 48. Sales Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Application (2016-2021)
Figure 49. Sales Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Application in 2020
Figure 50. Revenue Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Application (2016-2021)
Figure 51. Revenue Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Application in 2020
Figure 52. Manufacturing Cost Structure of Dipeptide Peptidase 4 (DPP-4) Inhibitors
Figure 53. Manufacturing Process Analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitors
Figure 54. Dipeptide Peptidase 4 (DPP-4) Inhibitors Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
